MMP-9响应型水凝胶用于活髓治疗的设计与评价
本研究设计了一种对基质金属蛋白酶9(MMP-9)响应的可注射光交联水凝胶,通过硫醇-降冰片烯光聚合将含肽连接子与四臂PEG-降冰片烯交联,并负载IDR-1002。体外实验表明,IDR-1002释放与MMP-9水平升高显著相关(p < 0.05),且水凝胶在10 nM或20 nM预激活MMP-9中浸泡时对多菌种口腔生物膜的杀菌效果显著增强(p < 0.05)。结论认为该水凝胶是活髓治疗中按需递送生物活性剂的候选材料。
要点
- MMP-9响应型水凝胶可成功合成,具备可注射和光交联特性
- IDR-1002释放与MMP-9水平升高显著相关(p < 0.05)
- 在10 nM或20 nM预激活MMP-9中杀菌效果显著增强(p < 0.05)
核心结论
- MMP-9响应型水凝胶是活髓治疗中按需递送生物活性剂的有前景候选材料。
- MMP-9是牙髓炎重要的诊断和预后生物标志物,该水凝胶有望作为牙髓炎症诊断和治疗的原地按需释放系统。
研究设计与样本
- 通过硫醇-降冰片烯光聚合将优化MMP-9敏感性的肽连接子与四臂PEG-降冰片烯交联,形成负载IDR-1002的水凝胶网络。
- 采用傅里叶变换红外光谱、扫描电镜、流变学测试和溶胀评价表征水凝胶及凝胶化动力学。
- 通过多次暴露于预激活MMP-9模拟牙髓炎症发作,评估水凝胶降解。
- 用高效液相色谱测量降解水凝胶释放的IDR-1002。
- 用共聚焦激光扫描显微镜评价释放的IDR-1002对一周龄多菌种口腔生物膜的效果。
主要发现
- 成功合成MMP-9响应、可注射且可光交联的水凝胶。
- 暴露于预激活MMP-9时,IDR-1002释放与MMP-9水平升高显著相关(p < 0.05)。
- 水凝胶浸泡于10 nM或20 nM预激活MMP-9时,IDR-1002杀灭多菌种口腔生物膜细菌的效果较浸泡于磷酸盐缓冲液显著增强(p < 0.05)。
关键数值与推荐
- IDR-1002释放与MMP-9水平升高显著相关(p < 0.05)。
- 在10 nM或20 nM预激活MMP-9中浸泡时杀菌效果显著增强(p < 0.05)。
临床怎么用
- 该水凝胶可根据牙髓炎症时MMP-9水平升高触发IDR-1002释放,实现按需给药。
- 有望用于牙髓炎的诊断和治疗,作为原地按需释放系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To design and evaluate a matrix metalloproteinase 9 (MMP-9)-responsive hydrogel for vital pulp therapy. METHODS: A peptide linker with optimized sensitivity toward MMP-9 was crosslinked with 4-arm poly (ethylene glycol)-norbornene (PEG-NB) by thiol-norbornene photo-polymerization. This resulted in the formation of a hydrogel network in which the peptide IDR-1002 was incorporated. Hydrogel characterization and gelation kinetics were examined with Fourier-transform infrared spectroscopy, scanning electron microscopy, rheological testing, and swelling evaluation. Hydrogel degradation was examined through multiple exposure to pre-activated MMP-9, to simulate flare-ups of dental pulp inflammation. The IDR-1002 released from degraded hydrogels was measured with high-performance liquid chromatography. Effect of IDR-1002 released from hydrogels on one-week-old multispecies oral biofilms was evaluated using confocal laser scanning microscopy. RESULTS: MMP-9-responsive, injectable, and photo-crosslinkable hydrogels were successfully synthesized. When hydrogel degradation and release of IDR-1002 were examined with exposure to pre-activated MMP-9, IDR-1002 release was significantly correlated with elevated levels of MMP-9 (p < 0.05). The effectiveness of IDR-1002 in killing bacteria in multispecies oral biofilms was significantly enhanced when the hydrogels were immersed in 10 nM or 20 nM pre-activated MMP-9, compared to immersion in phosphate-buffered saline (p < 0.05). CONCLUSIONS: The MMP-9-responsive hydrogel is a promising candidate for on-demand delivery of bioactive agent in vital pulp therapy. CLINICAL SIGNIFICANCE: MMP-9 is one of the most important diagnostic and prognostic biomarkers for pulpitis. An MMP-9-responsive hydrogel has potential to be used as an in-situ on-demand release system for the diagnosis and treatment of dental pulp inflammation.
引用
- Liu H, Yu J, Hieawy A, et al. Design and evaluation of an MMP-9-responsive hydrogel for vital pulp therapy. J Dent. 2024. PMID: 38670329. doi:10.1016/j.jdent.2024.105020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。